Lemaitre Vascular (LMAT) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $88.69 +10.04%
EPS Growth %: +11.3%
Financial Fact:
Cost of sales: 6.2M
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: +11.3%
Financial Fact:
Cost of sales: 6.2M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $35.9 million versus the consensus estimate of $35.2 million.
GUIDANCE:
Lemaitre Vascular sees Q2 2021 EPS of $0.28-$0.36, versus the consensus of $0.28. Lemaitre Vascular sees Q2 2021 revenue of $37-40 million, versus the consensus of $35.9 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Reservoir Media, Inc. (RSVR) Tops Q2 EPS by 2c; offers guidance
- CS Disco, Inc (LAW) Misses Q3 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
